Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Bionano Genomics Inc's Business Segments
Bionano Genomics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
1
Largest Segment
Reportable Segment
Total Revenue
$ 8
Regions Reported
3
Revenue Share by Reportable Segment - Q2 FY2026
- Reportable Segment100%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable Segment | $ 8 | 100% |
Revenue Share by Region - Q2 FY2026
- EMEA59.2%
- Americas37%
- Asia Pacific3.8%
Revenue by Geographic Region - Q2 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| EMEA | $ 5 | 59.2% |
| Americas | $ 3 | 37% |
| Asia Pacific | $ 0 | 3.8% |
Revenue by Product & Service Category - Q2 FY2026
- Product94.2%
- Consumable Revenue52.4%
- Instrument Revenue24.9%
- Software Revenue16.8%
- Product and Service Other5.9%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 8 | 94.2% |
| Consumable Revenue | $ 4 | 52.4% |
| Instrument Revenue | $ 2 | 24.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
2 more categories available
Sign in to unlock the full Bionano Genomics Inc dataset.
Description of Bionano Genomics Inc
Bionano Genomics Inc is a biotechnology company that specializes in genome mapping technology. It was founded in 2003 and is headquartered in San Diego, California. The company's primary focus is on developing and commercializing innovative tools for genome analysis.
Bionano Genomics has developed a unique and proprietary platform called Saphyr, which uses its patented nanochannel technology. This technology enables the accurate and precise mapping of complex structures of genomes. It allows researchers and scientists to study genomic variations and structural variations, such as large-scale copy number variants, inversions, and translocations.
The Saphyr system works by analyzing long DNA molecules in nanochannels, allowing the precise detection of structural variations across the genome. This method is faster and more cost-effective compared to traditional sequencing technologies. The Saphyr system also provides higher resolution and sensitivity, enabling the identification of structural variants that are often missed by other methods.
Bionano Genomics provides comprehensive solutions for genome analysis, including sample preparation kits, reagents, software, and informatics tools. The company offers researchers a complete package for analyzing genomes and understanding the complexities of genetic variation.
The applications of Bionano Genomics technology are vast and have the potential to benefit various fields, including human genetics, oncology, agricultural genomics, and genetic diseases research. The ability to accurately map and analyze genomes can aid in the identification and understanding of disease-causing genetic variants. It can also support the development of personalized medicine and targeted therapies.
Apart from its core technology, Bionano Genomics has also expanded its product portfolio through strategic partnerships and acquisitions. The company collaborated with leading research institutions and biotech companies to advance its technology and expand its market presence.
Bionano Genomics has gained significant recognition in the genomics industry for its breakthrough technology. It has received numerous awards and accolades, including being recognized as one of the fastest-growing companies in North America by Deloitte Technology Fast 500.
In summary, Bionano Genomics Inc is a leading biotechnology company that has developed a unique and innovative genome mapping platform, Saphyr. The company's technology has wide-ranging applications and has the potential to revolutionize genomic analysis, genomics research, and personalized medicine. Its commitment to innovation and collaboration positions it as a key player in the rapidly evolving genomics industry.
Bionano Genomics has developed a unique and proprietary platform called Saphyr, which uses its patented nanochannel technology. This technology enables the accurate and precise mapping of complex structures of genomes. It allows researchers and scientists to study genomic variations and structural variations, such as large-scale copy number variants, inversions, and translocations.
The Saphyr system works by analyzing long DNA molecules in nanochannels, allowing the precise detection of structural variations across the genome. This method is faster and more cost-effective compared to traditional sequencing technologies. The Saphyr system also provides higher resolution and sensitivity, enabling the identification of structural variants that are often missed by other methods.
Bionano Genomics provides comprehensive solutions for genome analysis, including sample preparation kits, reagents, software, and informatics tools. The company offers researchers a complete package for analyzing genomes and understanding the complexities of genetic variation.
The applications of Bionano Genomics technology are vast and have the potential to benefit various fields, including human genetics, oncology, agricultural genomics, and genetic diseases research. The ability to accurately map and analyze genomes can aid in the identification and understanding of disease-causing genetic variants. It can also support the development of personalized medicine and targeted therapies.
Apart from its core technology, Bionano Genomics has also expanded its product portfolio through strategic partnerships and acquisitions. The company collaborated with leading research institutions and biotech companies to advance its technology and expand its market presence.
Bionano Genomics has gained significant recognition in the genomics industry for its breakthrough technology. It has received numerous awards and accolades, including being recognized as one of the fastest-growing companies in North America by Deloitte Technology Fast 500.
In summary, Bionano Genomics Inc is a leading biotechnology company that has developed a unique and innovative genome mapping platform, Saphyr. The company's technology has wide-ranging applications and has the potential to revolutionize genomic analysis, genomics research, and personalized medicine. Its commitment to innovation and collaboration positions it as a key player in the rapidly evolving genomics industry.
Bionano Genomics Inc. is a biotechnology company that specializes in developing and commercializing optical genome mapping (OGM) technology. This technology is designed to enhance the understanding of genetic disorders and cancer through comprehensive genomic analysis. Below is an extensive overview of the segments, products, and services offered by Bionano Genomics Inc.
Segments
Bionano Genomics primarily operates in the following segments:
1. Genomic Analysis:
- This segment focuses on providing tools and solutions for genomic research and clinical applications. It is oriented towards hospitals, research institutions, and laboratories that require advanced genomic analysis to better understand genetic conditions and cancer.
2. Clinical Research and Diagnostics:
- Bionano aims to deliver solutions that aid in clinical decision-making and diagnostics, particularly for rare genetic disorders and in oncology settings. This is geared toward enhancing patient outcomes through improved genetic insights.
3. Pharmaceutical and Academic Research:
- This segment services pharmaceutical companies and academic institutions involved in genetic research, offering tools that facilitate drug development and research into genetic diseases.
Products
Bionano Genomics offers several key products under its optical genome mapping platform:
1. Saphyr System:
- The Saphyr System is Bionanos flagship device for optical genome mapping. It combines high-resolution imaging and advanced software algorithms to enable researchers to visualize long stretches of DNA in a way that traditional sequencing technologies cannot. The Saphyr System is capable of detecting structural variations, including large deletions, duplications, and complex rearrangements that might be missed by short-read sequencing technologies.
2. Bionano Prep Kits:
- These kits are designed to prepare genomic DNA samples for analysis on the Saphyr System. There are several specific kits offered, including those for extracting high molecular weight DNA, which is vital for maximizing the sensitivity and resolution of optical genome mapping.
3. Bionano Cloud:
- The Bionano Cloud is an online platform that supports data storage, processing, and analysis. It offers computational tools that enable users to analyze their genome mapping data and collaborate with other researchers, providing an integrated environment to interpret complex genomic data.
4. Data Analysis Software:
- Alongside the hardware and wet-lab preparations, Bionano Genomics provides sophisticated analysis software tailored to genomic data interpretation. This software includes algorithms and visualization tools that help in identifying and characterizing structural variants.
5. Genomic Services:
- Bionano offers genomic services which include sample processing, data acquisition, and analysis for researchers who may not have the infrastructure or expertise to perform these tasks in-house. This service facilitates access to Bionano’s advanced genomic mapping technology without requiring immediate investment in equipment.
Services
In addition to its product offerings, Bionano Genomics provides a range of services designed to enhance the customer experience and support research and clinical applications:
1. Technical Support and Training:
- Bionano provides comprehensive technical support to users of the Saphyr System and associated products. This includes training sessions for laboratory personnel to ensure proper operation, maintenance, and data analysis interpretation.
2. Consultation Services:
- The company offers consulting services to assist researchers and clinical labs in study design and implementation, particularly those looking to integrate optical genome mapping into their existing workflows.
3. Collaboration Opportunities:
- Bionano actively engages in partnerships with academic and research institutions to promote collaborative research initiatives that leverage its optical genome mapping technology.
4. Educational Resources:
- The company provides educational materials, webinars, and workshops aimed at enhancing the understanding of optical genome mapping and its applications in various fields of genetics and genomics.
Applications
The applications of Bionano Genomics’ products and services span a wide range of areas, including but not limited to:
- Oncology: Identifying structural variations in cancer genomes aids in better understanding tumor biology and developing personalized therapies.
- Rare Genetic Disorders: Enhancing the identification of genetic mutations associated with rare diseases, facilitating early diagnosis and intervention.
- Reproductive Health: Applications in prenatal testing, providing insights into chromosomal abnormalities that can affect fetal development.
- Clinical Trials: Supporting pharmaceutical companies in characterizing genetic alterations in patient populations for novel drug development.
In summary, Bionano Genomics Inc. offers a comprehensive suite of advanced genomic technologies and services aimed at enhancing genomic research, clinical diagnostics, and therapeutic development through its innovative optical genome mapping solutions. Each product and service is designed to improve understanding and management of genetic disorders, ultimately contributing to advancements in the field of genomics.
Segments
Bionano Genomics primarily operates in the following segments:
1. Genomic Analysis:
- This segment focuses on providing tools and solutions for genomic research and clinical applications. It is oriented towards hospitals, research institutions, and laboratories that require advanced genomic analysis to better understand genetic conditions and cancer.
2. Clinical Research and Diagnostics:
- Bionano aims to deliver solutions that aid in clinical decision-making and diagnostics, particularly for rare genetic disorders and in oncology settings. This is geared toward enhancing patient outcomes through improved genetic insights.
3. Pharmaceutical and Academic Research:
- This segment services pharmaceutical companies and academic institutions involved in genetic research, offering tools that facilitate drug development and research into genetic diseases.
Products
Bionano Genomics offers several key products under its optical genome mapping platform:
1. Saphyr System:
- The Saphyr System is Bionanos flagship device for optical genome mapping. It combines high-resolution imaging and advanced software algorithms to enable researchers to visualize long stretches of DNA in a way that traditional sequencing technologies cannot. The Saphyr System is capable of detecting structural variations, including large deletions, duplications, and complex rearrangements that might be missed by short-read sequencing technologies.
2. Bionano Prep Kits:
- These kits are designed to prepare genomic DNA samples for analysis on the Saphyr System. There are several specific kits offered, including those for extracting high molecular weight DNA, which is vital for maximizing the sensitivity and resolution of optical genome mapping.
3. Bionano Cloud:
- The Bionano Cloud is an online platform that supports data storage, processing, and analysis. It offers computational tools that enable users to analyze their genome mapping data and collaborate with other researchers, providing an integrated environment to interpret complex genomic data.
4. Data Analysis Software:
- Alongside the hardware and wet-lab preparations, Bionano Genomics provides sophisticated analysis software tailored to genomic data interpretation. This software includes algorithms and visualization tools that help in identifying and characterizing structural variants.
5. Genomic Services:
- Bionano offers genomic services which include sample processing, data acquisition, and analysis for researchers who may not have the infrastructure or expertise to perform these tasks in-house. This service facilitates access to Bionano’s advanced genomic mapping technology without requiring immediate investment in equipment.
Services
In addition to its product offerings, Bionano Genomics provides a range of services designed to enhance the customer experience and support research and clinical applications:
1. Technical Support and Training:
- Bionano provides comprehensive technical support to users of the Saphyr System and associated products. This includes training sessions for laboratory personnel to ensure proper operation, maintenance, and data analysis interpretation.
2. Consultation Services:
- The company offers consulting services to assist researchers and clinical labs in study design and implementation, particularly those looking to integrate optical genome mapping into their existing workflows.
3. Collaboration Opportunities:
- Bionano actively engages in partnerships with academic and research institutions to promote collaborative research initiatives that leverage its optical genome mapping technology.
4. Educational Resources:
- The company provides educational materials, webinars, and workshops aimed at enhancing the understanding of optical genome mapping and its applications in various fields of genetics and genomics.
Applications
The applications of Bionano Genomics’ products and services span a wide range of areas, including but not limited to:
- Oncology: Identifying structural variations in cancer genomes aids in better understanding tumor biology and developing personalized therapies.
- Rare Genetic Disorders: Enhancing the identification of genetic mutations associated with rare diseases, facilitating early diagnosis and intervention.
- Reproductive Health: Applications in prenatal testing, providing insights into chromosomal abnormalities that can affect fetal development.
- Clinical Trials: Supporting pharmaceutical companies in characterizing genetic alterations in patient populations for novel drug development.
In summary, Bionano Genomics Inc. offers a comprehensive suite of advanced genomic technologies and services aimed at enhancing genomic research, clinical diagnostics, and therapeutic development through its innovative optical genome mapping solutions. Each product and service is designed to improve understanding and management of genetic disorders, ultimately contributing to advancements in the field of genomics.